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EXECUTIVE SUMMARY 
Today’s knowledge on removal of pharmaceuticals in activated sludge systems and 
membrane bioreactors is rapidly increasing and has reached a level that makes discussions 
on potential optimisation strategies relevant. For biofilm systems, pharmaceutical removal is 
much less investigated, despite their frequent use. Clear comparative studies on removal of 
pharmaceuticals between moving bed biofilm reactors (MBBRs) and other biological 
treatments systems are also lacking. Accordingly, batch experiments with biofilm carriers and 
nitrifying activated sludge from several municipal WWTPs were carried out to assess the 
removal of seven pharmaceuticals. A distinct difference between nitrifying activated sludge 
and suspended biofilm carrier removal of the pharmaceuticals was demonstrated. The biofilm 
carriers demonstrated considerably higher removal rates per unit biomass (i.e. suspended 
solids for the sludges and attached solids for the carriers) of diclofenac, ketoprofen, 
gemfibrozil, clofibric acid and mefenamic acid compared to the sludges. Among the target 
pharmaceuticals, only ibuprofen and naproxen showed similar removal rates per unite 
biomass for the sludges and biofilm carriers.   
Carriers and sludge, for the batch experiments, were collected from several full-scale plants. 
All plants where characterized with respect to either the concentration of carriers or 
suspended solids. Further characterization was made with respect to sludge age and 
nitrification capacity for the activated sludges and with respect to surface area, biofilm mass 
and nitrification capacity for the carriers. Batch experiments and measurements of 
nitrification capacities were made in completely mixed and fully aerated batch reactors. 
Pharmaceuticals, 100 µg/L, were added to the reactors and 9 to 12 samples for 
pharmaceutical analysis were withdrawn from the reactors over 24 h. The samples were 
centrifuged, filtered, loaded on SPE-cartridges, Oasis HLB 3cc (60 mg), and analysed with a 
GC-MS, Agilent 5973N Mass Selective Detector. Measurements of pH, NO3-N, NO2-N and 
NH4-N were made.  
The observed pharmaceutical removal was generally much higher for suspended biofilm 
carriers than for activated sludges, which is showed for diclofenac and ketoprofen (Figure 1a 
and 1b). Furthermore, normalization of the first-order removal rates by the biomass 
concentration showed that the higher removal observed for the carriers compared to the 
sludges was most often induced by a higher removal capacity per unite biomass for the 
carriers than the sludges.  
       
Figure 1a and 1b. Observed removal of diclofenac (1a) and ketoprofen (1b) in the batch experiments.  
